Subject will be undergoing a primary Fenestrated Endovascular Aortic Repair (FEVAR) procedure (including subjects with prior infrarenal EVAR or open repair) that includes the incorporation of visceral arteries into the repair.
Subject is able to give informed consent and is 18 years of age or older, or of legal age to give informed consent per state or national law.
Subject has a life expectancy of at least 2 years
Target vessels to be included are the Celiac Trunk, Superior Mesenteric Artery and Renal Arteries
You may not be if
Subjects undergoing an endovascular procedure that include branches or iliac branched devices (IBD) in the repair
Subject treated for re-intervention / staged procedure post-primary FEVAR procedure
Subjects intended to be treated for more than 4 target vessels (not counting the contralateral gate)
Subject treated for an emergent (\<24hrs after emergence) procedure
Subject with connective tissue disorder eg, Marfan's or Ehlers Danlos Syndrome
Subject with contrast allergies
Subject participates in a potentially confounding drug or device trial during the course of the study. Co-enrollment in concurrent trials may be allowed provided that pre-approval is obtained from Philips.
Subject unwilling or unable to comply with the protocol unable to understand verbal and/or written informed consent
